Jim Al­li­son launch­es new in­sti­tute aimed at speed­ing drug de­vel­op­ment and rais­ing 'sur­vival curve for all can­cer­s'

Jim Al­li­son’s name is linked to a 2018 No­bel Prize, the im­mune sys­tem-ac­ti­vat­ing can­cer med Yer­voy and a host of ac­co­lades across his mul­ti-decade ca­reer in im­munother­a­py and T cell re­search.

Now, as part of MD An­der­son Can­cer Cen­ter’s push for new break­throughs this decade, he’s launched an epony­mous in­sti­tute along­side sci­en­tif­ic di­rec­tor Pad­ma­nee Shar­ma and op­er­a­tions leader Raghu Kalluri.

Unlock this article instantly by becoming a free subscriber.

You’ll get access to free articles each month, plus you can customize what newsletters get delivered to your inbox each week, including breaking news.

SIGN UP LOG IN BECOME A PREMIUM SUBSCRIBER